These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 2844899

  • 1. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides.
    Renz H, Gong JH, Schmidt A, Nain M, Gemsa D.
    J Immunol; 1988 Oct 01; 141(7):2388-93. PubMed ID: 2844899
    [Abstract] [Full Text] [Related]

  • 2. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S, Gong JH, Schmidt A, Nain M, Gemsa D.
    J Immunol; 1989 Aug 15; 143(4):1198-205. PubMed ID: 2473121
    [Abstract] [Full Text] [Related]

  • 3. Regulation of lipopolysaccharide-induced tumor necrosis factor alpha production by endogenous prostaglandin E2 in rat resident and thioglycollate-elicited macrophages.
    Watanabe S, Kobayashi T, Okuyama H.
    J Lipid Mediat Cell Signal; 1994 Sep 15; 10(3):283-94. PubMed ID: 7812678
    [Abstract] [Full Text] [Related]

  • 4. Divergence in macrophage insulin-like growth factor-I (IGF-I) synthesis induced by TNF-alpha and prostaglandin E2.
    Fournier T, Riches DW, Winston BW, Rose DM, Young SK, Noble PW, Lake FR, Henson PM.
    J Immunol; 1995 Aug 15; 155(4):2123-33. PubMed ID: 7636260
    [Abstract] [Full Text] [Related]

  • 5. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells.
    Endres S, Fülle HJ, Sinha B, Stoll D, Dinarello CA, Gerzer R, Weber PC.
    Immunology; 1991 Jan 15; 72(1):56-60. PubMed ID: 1847694
    [Abstract] [Full Text] [Related]

  • 6. Modulation of tumor necrosis factor-alpha gene expression. Desensitization of prostaglandin E2-induced suppression.
    Spengler RN, Spengler ML, Strieter RM, Remick DG, Larrick JW, Kunkel SL.
    J Immunol; 1989 Jun 15; 142(12):4346-50. PubMed ID: 2723432
    [Abstract] [Full Text] [Related]

  • 7. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG, Burger CJ, Elgert KD.
    J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of tumor necrosis factor-alpha gene expression by low doses of prostaglandin E2 and cyclic GMP.
    Gong JH, Renz H, Sprenger H, Nain M, Gemsa D.
    Immunobiology; 1990 Dec 15; 182(1):44-55. PubMed ID: 1965895
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E2 affects differently the release of inflammatory mediators from resident macrophages by LPS and muramyl tripeptides.
    Dieter P, Hempel U, Kamionka S, Kolada A, Malessa B, Fitzke E, Tran-Thi TA.
    Mediators Inflamm; 1999 Dec 15; 8(6):295-303. PubMed ID: 10815618
    [Abstract] [Full Text] [Related]

  • 10. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages.
    Chen BC, Hsieh SL, Lin WW.
    J Leukoc Biol; 2001 Feb 15; 69(2):280-8. PubMed ID: 11272279
    [Abstract] [Full Text] [Related]

  • 11. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM, Barnes PJ, Meja K, Giembycz MA.
    Mol Pharmacol; 1995 Oct 15; 48(4):747-57. PubMed ID: 7476903
    [Abstract] [Full Text] [Related]

  • 12. Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP.
    Katakami Y, Nakao Y, Koizumi T, Katakami N, Ogawa R, Fujita T.
    Immunology; 1988 Aug 15; 64(4):719-24. PubMed ID: 2844658
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
    Vaday GG, Schor H, Rahat MA, Lahat N, Lider O.
    J Leukoc Biol; 2001 Apr 15; 69(4):613-21. PubMed ID: 11310848
    [Abstract] [Full Text] [Related]

  • 14. Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.
    Scales WE, Chensue SW, Otterness I, Kunkel SL.
    J Leukoc Biol; 1989 May 15; 45(5):416-21. PubMed ID: 2651547
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S, Weyers M, Gong JH, Sprenger H, Nain M, Gemsa D.
    J Immunol; 1988 Mar 01; 140(5):1511-8. PubMed ID: 3126228
    [Abstract] [Full Text] [Related]

  • 16. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
    Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP.
    J Immunol; 1998 Apr 01; 160(7):3513-21. PubMed ID: 9531313
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM, Barnes PJ, Giembycz MA.
    Cell Biochem Biophys; 1998 Apr 01; 29(1-2):179-201. PubMed ID: 9631245
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP.
    Lehmmann V, Benninghoff B, Dröge W.
    J Immunol; 1988 Jul 15; 141(2):587-91. PubMed ID: 2838550
    [Abstract] [Full Text] [Related]

  • 19. Evidence for endogenous C1q modulates TNF-alpha receptor synthesis and autocrine binding of TNF-alpha associated with lipid A activation of murine macrophages for nitric oxide production.
    Jiang H, Rummage JA, Stewart CA, Herriott MJ, Kolosova I, Kolosov M, Leu RW.
    Cell Immunol; 1996 May 25; 170(1):34-40. PubMed ID: 8660797
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of increased tumor necrosis factor production after thermal injury. Altered sensitivity to PGE2 and immunomodulation with indomethacin.
    Molloy RG, O'Riordain M, Holzheimer R, Nestor M, Collins K, Mannick JA, Rodrick ML.
    J Immunol; 1993 Aug 15; 151(4):2142-9. PubMed ID: 8345198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.